JANG, KYOUNG HWA,장경화,KANG, SEOK CHAN,강석찬,JANG, DO SOO,장도수,KIM, YOUNG MOK,김영목,KIM WANSEOP PAUL,김완섭폴,UM, KEY AN,엄기안,JANG, KYOUNG HWAKR,KANG, SEOK CHANKR,JANG, DO SOOKR,KIM, YOUNG MOKKR,KIM WANSEOP PAULUS,UM, KEY ANKR
申请号：
KR1020170074962
公开号：
KR1019109080000B1
申请日:
2017.06.14
申请国别(地区):
KR
年份:
2018
代理人:
摘要：
The present invention relates to a pharmaceutical composition for the treatment of dry eye syndrome having Gly-Tβ44 as an active ingredient, which is used for treating corneal epithelial cells and proliferating Goblet cells. Therefore, it is effective in the treatment, prevention and alleviation of the dry eye syndrome.본 발명은 Gly-Tβ4를 유효성분으로 하는 안구건조증 치료용 약학적 조성물로서, 손상된 각막 상피세포를 회복시키고, 동시에 Goblet cell(술잔세포)가 증식시키는 효과를 보이므로, 안구건조증의 치료, 예방, 경감에 효과적이다.
